Cancer Research UK logo.
SearchDonate
  • Search

A trial comparing usual treatment with pembrolizumab for bowel cancer that has spread (KEYNOTE 177)

Overview

Cancer types:

Bowel (colorectal) cancer, Colon cancer, Rectal cancer

Status:

Closed

Phase:

Phase 3

Details

This trial is open to people with certain gene changes (mutations) in the bowel cancer genes. These gene changes are microsatellite instability high (MSI-H) or mismatch repair deficiency (dMMR).

Recruitment start: 12 May 2016

Recruitment end: 13 May 2018

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Kai-Keen Shiu

Supported by

Merck Sharp & Dohme Ltd

Last reviewed: 31 May 2018

CRUK internal database number: 14095

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.